Abstract:A rational design strategy of the novel podophyllum topoisomerase II (Topo II) inhibitors for the synthesis of the esterification and amidation substituted 4′-demethylepipodophyllotoxin (DMEP) derivates was developed in order to discover the potential antitumor prodrug. Firstly, according to the structure–activity relationship, drug combination principle and bioisosterism, the –COO– and the –NH– bond substituents at the 4 position of cycloparaffin would be a great modification direction to improve antitumor activity of 4′-demethylepipodophyllotoxin (DMEP). Secondly, from the prodrug principle view, the esterification and amidation at the C-4 position of DMEP would be two useful structure modifications for improve solubility. Thirdly, from the activity pocket in Topo II-DNA cleavage complex point of view, a series of heterocyclic with pharmacological activity were chosen as module for improving antitumor activity by binding with Topo II. Finally, nine novel esterification and amidation DMEP derivates were designed and synthesized for the potential Topo II inhibitors with the superior biological activity. All the novel compounds exhibited promising in vitro antitumor activity, especially 4-O-(2-pyrazinecarboxylic)-4′-demethylepipodophyllotoxin (compound 1). The antitumor activity of compound 1 against tumor cell line HeLa (i.e., the IC50 value of 0.60±0.20μM), A549 (i.e., the IC50 value of 3.83±0.08μM), HepG2 (i.e., the IC50 value of 1.21±0.05μM), and BGC-823 (i.e., the IC50 value of 4.15±1.13μM) was significantly improved by 66, 16, 12, and 6 times than that of the clinically important podophyllum anticancer drug etoposide (i.e., the IC50 values of 15.32±0.10, 59.38±0.77, 67.25±7.05, and 30.74±5.13μM), respectively. Compound 1 could arrest HeLa cell cycle G2/M and induce apoptosis by strongly diminishing the relaxation reaction of Topo II-DNA decatenation. The correctness of rational drug design was strictly demonstrated by the bioactivity test.

Design and Synthesis of the Novel DNA Topoisomerase II Inhibitors: Esterification and Amination Substituted 4'-Demethylepipodophyllotoxin Derivates Exhibiting Anti-Tumor Activity by Activating ATM/ATR Signaling Pathways.

A Rational Design Strategy of the Novel Topoisomerase II Inhibitors for the Synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with Antitumor Activity by Diminishing the Relaxation Reaction of Topoisomerase II-DNA Decatenation.

Synthesis and Biological Evaluation of 4Β-(Thiazol-2-yl)amino-4'-o-demethyl-4-deoxypodophyllotoxins As Topoisomerase-Ii Inhibitors.

Novel 4β-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents

Design and Synthesis of 2-Phenylnaphthalenoids As Inhibitors of DNA Topoisomeraseiiα and Antitumor Agents.

Synthesis and Biological Evaluation of Xanthone Derivatives As Anti-Cancer Agents Targeting Topoisomerase II and DNA

Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents.

Crystal Structures, Molecular Docking and In Vitro Investigations of Two 4-Substituted 2-(5,5-dimethyl-3-styrylcyclohex-2-enylidene)malononitrile Derivatives as Potential Topoisomerase II Inhibitors

Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives As Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.

Synthesis and Biological Activities of 11-and 12-Substituted Benzophenanthridinone Derivatives As DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors

Synthesis and Biological Evaluation of N -(Carbobenzyloxy)- L -Phenylalanine and N -(Carbobenzyloxy)- L -Aspartic Acid- Β -Benzyl Ester Derivatives As Potent Topoisomerase IIα Inhibitors

A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.

Design and Synthesis of 2-Phenylnaphthalenoids and 2-Phenylbenzofuranoids As DNA Topoisomerase Inhibitors and Antitumor Agents

The Discovery and Optimization of Novel Dual Inhibitors of Topoisomerase Ii and Histone Deacetylase

Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity

Design and synthesis of novel multi-target tetrabromophthalimides as CBS and Topo-II inhibitors and DNA intercalators

Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons

Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents

Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.

Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors